EGFR and lung adenocarcinoma: EGFR driver mutations are the most common, particularly in Asians, women, and nonsmokers [2,3,4,5], and more than 40% of Japanese patients with lung adenocarcinoma are EGFR mutation-positive (EGFRm+) [6,7].